Journey Medical Corp (DERM)
NASDAQ:DERM
Want to see DERM full AI Analyst Report?
Total Valuation
Journey Medical Corp has a market cap or net worth of $172.64M. The enterprise value is $171.91M.
Market Cap$172.64M
Enterprise Value$171.91M
Share Statistics
Journey Medical Corp has 21,534,548 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding21,534,548
Owned by Insiders19.18%
Owned by Institutions32.16%
Financial Efficiency
Journey Medical Corp’s return on equity (ROE) is -0.36 and return on invested capital (ROIC) is -14.27%.
Return on Equity (ROE)-0.36
Return on Assets (ROA)-0.12
Return on Invested Capital (ROIC)-14.27%
Return on Capital Employed (ROCE)-0.14
Revenue Per Employee1.51M
Profits Per Employee-278.80K
Employee Count41
Asset Turnover0.65
Inventory Turnover2.62
Valuation Ratios
The current PE Ratio of Journey Medical Corp is ―. Journey Medical Corp’s PEG ratio is 0.48.
PE Ratio―
PS Ratio3.05
PB Ratio5.93
Price to Fair Value5.93
Price to FCF-15.18
Price to Operating Cash Flow-25.27
PEG Ratio0.48
Income Statement
In the last 12 months, Journey Medical Corp had revenue of 61.86M and earned -11.43M in profits. Earnings per share was -0.47.
Revenue61.86M
Gross Profit36.68M
Operating Income-8.17M
Pretax Income-11.37M
Net Income-11.43M
EBITDA-3.33M
Earnings Per Share (EPS)-0.47
Cash Flow
In the last 12 months, operating cash flow was -6.78M and capital expenditures 0.00, giving a free cash flow of -6.78M billion.
Operating Cash Flow-6.78M
Free Cash Flow-6.78M
Free Cash Flow per Share-0.31
Dividends & Yields
Journey Medical Corp pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.49
52-Week Price Change-10.04%
50-Day Moving Average5.53
200-Day Moving Average7.16
Relative Strength Index (RSI)58.32
Average Volume (3m)296.62K
Important Dates
Journey Medical Corp upcoming earnings date is Aug 11, 2026, Before Open (Confirmed).
Last Earnings DateMay 13, 2026
Next Earnings DateAug 11, 2026
Ex-Dividend Date―
Financial Position
Journey Medical Corp as a current ratio of 1.79, with Debt / Equity ratio of 82.60%
Current Ratio1.79
Quick Ratio1.53
Debt to Market Cap<0.01
Net Debt to EBITDA6.27
Interest Coverage Ratio-2.21
Taxes
In the past 12 months, Journey Medical Corp has paid 60.00K in taxes.
Income Tax60.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Journey Medical Corp EV to EBITDA ratio is -43.10, with an EV/FCF ratio of -13.26.
EV to Sales2.67
EV to EBITDA-43.10
EV to Free Cash Flow-13.26
EV to Operating Cash Flow-13.26
Balance Sheet
Journey Medical Corp has $27.22M in cash and marketable securities with $25.47M in debt, giving a net cash position of $1.75M billion.
Cash & Marketable Securities$27.22M
Total Debt$25.47M
Net Cash$1.75M
Net Cash Per Share$0.08
Tangible Book Value Per Share$0.17
Margins
Gross margin is 60.41%, with operating margin of -13.21%, and net profit margin of -18.48%.
Gross Margin60.41%
Operating Margin-13.21%
Pretax Margin-18.38%
Net Profit Margin-18.48%
EBITDA Margin-6.19%
EBIT Margin-13.21%
Analyst Forecast
The average price target for Journey Medical Corp is $13.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$13.50
Price Target Upside150.46% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast15.00%
EPS Growth Forecast3.18%